FI940309A - Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboxamid - Google Patents

Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboxamid Download PDF

Info

Publication number
FI940309A
FI940309A FI940309A FI940309A FI940309A FI 940309 A FI940309 A FI 940309A FI 940309 A FI940309 A FI 940309A FI 940309 A FI940309 A FI 940309A FI 940309 A FI940309 A FI 940309A
Authority
FI
Finland
Prior art keywords
tenoyl
oxindole
carboxamide
fluoro
chloro
Prior art date
Application number
FI940309A
Other languages
English (en)
Finnish (fi)
Other versions
FI940309A0 (sv
Inventor
Kelvin Cooper
Thomas C Crawford
Bruce H Littman
Christopher J Pazoles
Sally G Ruggeri
Keith D Wilner
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/007,217 external-priority patent/US5298522A/en
Application filed by Pfizer filed Critical Pfizer
Publication of FI940309A0 publication Critical patent/FI940309A0/sv
Publication of FI940309A publication Critical patent/FI940309A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI940309A 1993-01-22 1994-01-21 Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboxamid FI940309A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/007,217 US5298522A (en) 1993-01-22 1993-01-22 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
US13827793A 1993-10-18 1993-10-18

Publications (2)

Publication Number Publication Date
FI940309A0 FI940309A0 (sv) 1994-01-21
FI940309A true FI940309A (sv) 1994-07-23

Family

ID=26676677

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940309A FI940309A (sv) 1993-01-22 1994-01-21 Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboxamid

Country Status (27)

Country Link
EP (1) EP0680321B1 (sv)
JP (1) JP2711939B2 (sv)
CN (1) CN1116822A (sv)
AP (1) AP468A (sv)
AT (1) ATE171373T1 (sv)
AU (1) AU671533B2 (sv)
BG (1) BG61966B1 (sv)
BR (1) BR9405661A (sv)
CA (1) CA2153050C (sv)
CZ (1) CZ182895A3 (sv)
DE (1) DE69413518T2 (sv)
DK (1) DK0680321T3 (sv)
DZ (1) DZ1748A1 (sv)
ES (1) ES2122236T3 (sv)
FI (1) FI940309A (sv)
HU (1) HUT69687A (sv)
IL (1) IL108326A0 (sv)
LV (1) LV10920B (sv)
MA (1) MA23095A1 (sv)
NO (1) NO952904L (sv)
NZ (1) NZ261449A (sv)
OA (1) OA10173A (sv)
PL (1) PL309957A1 (sv)
SK (1) SK91395A3 (sv)
UY (1) UY23723A1 (sv)
WO (1) WO1994016694A1 (sv)
YU (1) YU48719B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE10106852A1 (de) * 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
DE4111306C2 (de) * 1991-04-08 1994-06-01 Mack Chem Pharm Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio

Also Published As

Publication number Publication date
CN1116822A (zh) 1996-02-14
UY23723A1 (es) 1994-06-28
DE69413518D1 (en) 1998-10-29
ATE171373T1 (de) 1998-10-15
ES2122236T3 (es) 1998-12-16
AU6019894A (en) 1994-08-15
EP0680321B1 (en) 1998-09-23
MA23095A1 (fr) 1994-10-01
SK91395A3 (en) 1996-12-04
FI940309A0 (sv) 1994-01-21
CZ182895A3 (en) 1996-01-17
LV10920B (en) 1996-04-20
LV10920A (lv) 1995-12-20
DZ1748A1 (fr) 2002-02-17
BG99767A (bg) 1996-02-28
OA10173A (en) 1996-12-18
AP468A (en) 1996-03-05
DK0680321T3 (da) 1999-06-14
IL108326A0 (en) 1994-04-12
CA2153050A1 (en) 1994-08-04
PL309957A1 (en) 1995-11-13
YU48719B (sh) 1999-07-28
NO952904D0 (no) 1995-07-21
BG61966B1 (bg) 1998-11-30
WO1994016694A1 (en) 1994-08-04
NO952904L (no) 1995-07-21
YU2394A (sh) 1996-10-18
JP2711939B2 (ja) 1998-02-10
NZ261449A (en) 1996-08-27
AU671533B2 (en) 1996-08-29
BR9405661A (pt) 1995-11-21
JPH08501109A (ja) 1996-02-06
DE69413518T2 (de) 1999-02-11
AP9400609A0 (en) 1994-01-31
HU9400176D0 (en) 1994-05-30
EP0680321A1 (en) 1995-11-08
HUT69687A (en) 1995-09-28
CA2153050C (en) 1998-12-29

Similar Documents

Publication Publication Date Title
FI935223A (fi) Rake-mottagare med selektiv kombinering av straolar
FI944885A (sv) Burkstomme
FI934971A0 (fi) Anlaeggning foer foerbraenning av spraengaemnen
FI930376A (fi) Tillslutningsanordning av gaengtyp med saekringsorgan
ZA94436B (en) Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide
FI960425A0 (sv) Användning av fenylcyklohexylkarboxylsyraamider
NO940190D0 (no) Anvendelse av x-ketoglutarat
MX9206026A (es) Procedimiento de alquilacion de isoalcan-olefinas
FI940309A (sv) Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboxamid
NO931399D0 (no) Anvendelse av naturstein
FI923360A (fi) Foerfarande foer framstaellning av dimetylacetoacetamid
DK36193D0 (da) Fremgangsmaade
FI925493A0 (fi) Rumselementsystem foer ersaettning av vaotutrymmen med tillfaelligutrymmeni samband med byggnadsarbeten
FI932658A0 (fi) Foerfarande foer framstaellning av viskosfibrer med bandformade tvaersnitt
DE69322081D1 (de) Salze von chinolon carbonsäuren
KR930026760U (ko) Tvcr의 개선된 구성
KR950013629U (ko) 제함기의 제함장치
LV10073A (lv) Skidinataju absolutizesanas panemiens
FI932887A0 (fi) Foerbaettrat foerfarande foer framstaellning av 4-nitro-3-trifluorometylanilin
SV1993000010A (es) Preparacion de nuevas sulfonamidocarboxamidas
FI930700A0 (fi) Anordningar foer avlaegsnande av goedsel
SE9302529D0 (sv) Maximal anvaendning av solfaangare
SE9203936D0 (sv) Framstaellning av engaangstrummor
SE9200478D0 (sv) Framstaellning av engaangstrummor
BR9306699A (pt) Derivados do triazoliletanol